Sonolisib
- Generic Name
- Sonolisib
- Drug Type
- Small Molecule
- Chemical Formula
- C29H35NO8
- CAS Number
- 502632-66-8
- Unique Ingredient Identifier
- 987796874T
- Background
Sonolisib has been used in trials studying the treatment of Glioblastoma, Prostate Cancer, Advanced Solid Tumors, Advanced BRAF-mutant Cancers, and Non Small Cell Lung Cancer (NSCLC), among others.
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath